| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
F2RL1 |
F2RL1, GPR11, PAR2: Proteinase-activated receptor 2 precursor |
0.78 |
Evidence |
|
| CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.78 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
0.78 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.78 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.78 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TRAF2 |
TRAF2, TRAP3: TNF receptor-associated factor 2 |
0.78 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
MST1R |
MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor |
0.78 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
CTNND2 |
CTNND2, NPRAP: Catenin delta-2 |
0.78 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
0.78 |
Evidence |
|
| CD44 |
IPI00305064 |
MMP13 |
MMP13: Collagenase 3 precursor |
0.78 |
Evidence |
|
| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
0.78 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.78 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
IL12RB2 |
IL12RB2: Interleukin-12 receptor beta-2 chain precursor |
0.78 |
Evidence |
|
| OSM |
OSM: Oncostatin-M precursor |
PRLR |
PRLR: Prolactin receptor precursor |
0.78 |
Evidence |
|
| CCL5 |
CCL5, D17S136E, SCYA5: Small-inducible cytokine A5 precursor |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.78 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.78 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.78 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.78 |
Evidence |
|
| CCL4 |
CCL4, CCL4L, LAG1, MIP1B, SCYA4, SCYA4L: Small-inducible cytokine A4 precursor |
FPR1 |
FPR1: fMet-Leu-Phe receptor |
0.78 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
0.78 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
0.78 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
0.78 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.78 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
P2RY4 |
P2RY4, NRU: P2Y purinoceptor 4 |
0.78 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
0.78 |
Evidence |
|